SEC Form 4 · accession 0000899243-18-031718
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
E. Brendan Magrab
Director
Period of report
Dec 20, 2018
Accepted (ET)
Dec 26, 2018 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2018 | A | 65,000 | $0.08 | A | 65,000 | D |
Table II — derivative securities
No Table II lines on this filing.